| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.056 | 0.4 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.039 | 0.5 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.033 | 0.5 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.041 | 0.5 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.033 | 0.5 |